EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST), a worldwide leader in providing innovative solutions for injectable drug administration, has announced that its Board of Directors has approved a first-quarter dividend for 2024. The dividend is set at $0.20 per share.
West Pharmaceutical Services has scheduled the dividend payment for February 7, 2024. To be eligible for this dividend, investors must be recorded shareholders as of January 31, 2024.
This decision by the Board of Directors follows the company’s established tradition of providing regular quarterly dividends to its shareholders. The most recent ex-dividend date was November 7, 2023, when the company distributed $0.20 per share.
The declaration of this dividend underscores West Pharmaceutical Services’ commitment to its shareholders and its confidence in the company’s financial stability. The company continues to demonstrate a strong performance in the market, with a stock price reported at $341.19 as of December 7, 2023.
CEO David Musto expressed his optimism about the company’s future. “As we continue to lead in innovative solutions for injectable drug administration, we are pleased to share our success with our valued shareholders,” said Musto.
Investors looking forward to this dividend payout can anticipate further announcements from West Pharmaceutical Services regarding its ongoing performance and future dividends.
West Pharmaceutical Services, Inc. specializes in providing technologically advanced solutions for injectable drug administration. Their services include designing and manufacturing packaging components and delivery systems for injectable drugs and healthcare products.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.